Fadwa ALHALAIQA, Ahmad AL-NAWAFLEH, Abdul-Monim BATIHA, Rami MASA DEH, Aida ABD AL-RAZEK

3119

A descriptive study of adherence to lifestyle modification factors among hypertensive patients

A descriptive study of adherence to lifestyle modification factors among hypertensive patients

Background/aim: Healthy life style recommendations (e.g., physical activity, healthy diet, and decreased cholesterol levels) play an important role in controlling blood pressure (BP). This study aimed to assess lifestyle modification factors among patients diagnosed with hypertension. Materials and methods: A descriptive-survey design was used. Data were collected using four questionnaires; one was the Beliefs about Medication questionnaire (BMQ) and the rest were developed to collect data about demographic and clinical characteristics and lifestyle modification factors. Results: In total 312 questionnaires were completed. The results revealed that our participants did not follow the healthy lifestyle recommendations; for example, the mean blood sugar (BS) level, body mass index (BMI), and cholesterol levels were 155 mg/dL (standard deviation (SD) = 71.9), 29 kg/m2 (SD = 5.4), and 197 mg/dL (SD = 86.6), respectively. A significant correlation was shown between age and BP (P = 0.000). Increase in diastolic BP (DBP) correlated with a significant increase in cholesterol level (P = 0.002) and BMI (P = 0.006). Conclusion: Our study showed that somewhat hypertensive patients in Jordan did not follow a healthy lifestyle. Therefore, urgent action by addressing behavioral risk factors has a positive impact on preventing and controlling hypertension.
PDF

___

  • 1. WHO. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization, 2011.
  • 2. Alhalaiqa F, Deane K, Nawafleh A, Clark A, Gray R. Adherence therapy for medication non-compliant patients with hypertension: a randomised controlled trial. J Hum Hypertens 2012; 26: 117-126.
  • 3. WHO. A global brief on hypertension. Silent killer, global public health crisis. Geneva: World Health Organization, 2013.
  • 4. Ministry of Health. Directorate of Information Studies and Research, Ministry of Health, The Hashemite Kingdom of Jordan. Mortality in Jordan 2005. Amman (JO), 2008.
  • 5. Alhalaiqa F, Masa’Deh R, Batiha AM, Deane K. Validity of Arabic version of Beliefs about Medication Questionnaire. CNR 2015; 24: 539-555.
  • 6. WHO. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization, 2008.
  • 7. WHO. 2008-2013 Action plan for the global strategy for the prevention and control of noncommunicable diseases: World Health Organization, 2009.
  • 8. World Economic Forum, Harvard School of Public Health. The Global Economic Burden of Non-communicable Diseases: World Economic Forum and the Harvard School of Public Health, 2011.
  • 9. World Health Organization and World Economic Forum. From Burden to “Best Buys”: Reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries. Geneva: World Health Organization and World Economic Forum, 2011.
  • 10. Jaddou H, Bateiha A, Al-Khateeb M, Ajlouni K. Epidemiology and management of hypertension among Bedouins in Northern Jordan. Saudi Med J 2003; 24: 472-476.
  • 11. Al-Drabah E, Irshaid Y, Yasein N, Zmeili S. Prescription pattern of antihypertensive drugs in Family Practice Clinics at Jordan University Hospital. Med-Science 2013; 2: 469-488.
  • 12. Naddaf A. Lifestyle of hypertensive patients and their drug compliance. Bull Pharm Sci 2004; 27: 307-314.
  • 13. Al-Nsour M, Zindah M, Belbeisi A, Hadaddin R, Brown DW, Walke H. Prevalence of selected chronic, noncommunicable disease risk factors in Jordan: results of the 2007 Jordan Behavioral Risk Factor Surveillance Survey. CDC - Preventing Chronic Disease 2012; 9: 11-0077.
  • 14. Bulatova N, Yousef AM, AbuRuz SD, Abu Farha R. Hypertension management and factors associated with blood pressure control in Jordanian patients attending cardiology clinic. TJPR 2013; 12: 827-33.
  • 15. WHO. Adherence to long-term therapies evidence for action. World Health Organization, 2003.
  • 16. Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, Jones D, Materson B, Oparil S, Wright JJ et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
  • 17. Al-Qasem A, Smith F, Clifford S. Adherence to medication among chronic patients in Middle Eastern countries: review of studies. East Mediterr Health J 2011; 17: 356-363.
  • 18. Bacon S, Sherwood A, Hinderliter A, Blumenthal J. Effects of exercise, diet and weight loss on high blood pressure. Sports Med 2004; 34: 307-316.
  • 19. Alderman MH. Non-pharmacological treatment of hypertension. Lancet 1994; 344: 307-311.
  • 20. He J, Whelton PK, Appel LJ, Charleston J, Klag MJ. Longterm effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000; 35: 544-549.
  • 21. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999; 4: 1-24.
  • 22. Al-Motassem F Y, Bulatova Nl, AbuRuz S. Management of coronary artery disease in Jordan: cross-sectional comparative study. JJPS 2008; 1: 28-40.
  • 23. Batiha A-M, AlAzzam M, ALBashtawy M, Tawalbeh L, Tubaishat A, Alhalaiqa F. The relationship between hypertension and anthropometric indices in a Jordanian population. Adv Stud Biol 2015; 7: 233-243.
  • 24. Al-Bdour MD, Al-Till MI, Abu Samra KM. Risk Factors for Diabetic Retinopathy among Jordanian Diabetics. Middle East Afr J Ophthalmol 2008 ;15:77-80.
  • 25. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell’Italia LJ, Calhoun DA. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009; 54: 475-481.
  • 26. Cook N, Cutler J, Obarzanek E, Buring J, Rexrode K, Kumanyika S, Appel L, Whelton P. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). Brit Med J 2007; 334: 885-888.
  • 27. Wexler R, Aukerman G. Nonpharmacologic strategies for managing hypertension. Am Fam Physician 2006; 73: 1953- 1956.
  • 28. Gao X, Wang G, Wang A, Xu T, Tong W, Zhang Y. Comparison of lipid accumulation product with body mass index as an indicator of hypertension risk among Mongolians in China. ORCB 2013; 7: e308-e14.
  • 29. Dua S, Bhuker M, Sharma P, Dhall M, Kapoor S. Body mass index relates to blood pressure among adults. North Am J Med Sci 2014; 6: 89-95.
  • 30. Paczkowska A, Koligat D, Nowakowska E, Hoffmann K, Bryl W. Analysis of direct costs of hypertension treatment among adolescents in Poland. Acta Pol Pharm 2014; 71: 197-203.
  • 31. Xu K, Ragain R. Effects of weight status on the recommendations of and adherence to lifestyle modifications among hypertensive adults. J Hum Hypertens 2005; 19: 365-371.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Arşiv
Sayıdaki Diğer Makaleler

Mahmut YÜKSEL, Sabite KACAR, Muhammet Yener AKPINAR, Fatih SAYGILI, Meral Akdoğan KAYHAN, Selçuk DİŞİBEYAZ, Yasemin ÖZİN, Mustafa KAPLAN, İhsan ATEŞ, Ertuğrul KAYAÇETİN

Can Hüseyin HEKİMOĞLU, Figen KAPTAN, İlknur VARDAR, Serap URAL, Nesrin TÜRKER, Bahar ÖRMEN, Nurbanu SEZAK, Sib EL

Zafer GÖREN, Mahluga J. DEMIRKAPU, Gökçe Akpinar ACET, SANDA ÇALI, Medine Gülçebi İdriz OĞLU

Mona Mohamed ZAKI, HALA ABDEL-AL, Mohamed AL-SAWI

Özge Özer KAYA, Altuğ KOÇ, Taha Reşid ÖZDEMİR, Özgür KIRBIYIK, Berk ÖZYILMAZ, Mehmet ÖZEREN, Deniz Can ÖZTEKİN, Cüneyt Eftal TANER, Yaşar Bekir KUTBAY

Derya Çakir ERDOĞAN, Füsun CÖMERT, ELİF AKTAŞ SEPETCİ, Fürüzan KÖKTÜRK, Canan KÜLAH

Andrei Mihai MALUTAN, Tudor DRUGAN, RAZVAN CIORTEA, Carmen BUCURI, MARIA PATRICIA RADA, Dan MIHU

Dysregulation of the DKK1 gene in pediatric B-cell acute lymphoblastic leukemia

Özden HATIRNAZ NG, Müge SAYİTOĞLU, Sinem FIRTINA, Yücel ERBİLGİN, Uğur ÖZBEK

Hacer Doğanay AYDIN, Doğa VURALLI, Didem Tuba AKÇALI, Hayrunnisa Bolay BELEN

Identification of the cysteine-rich 61 (CYR61) gene variations in osteosarcoma patients

Vijay KUMAR, Ajai SINGH, Vineet KUMAR, Syed Rizwan HUSSAIN, Abbas Ali MAHDI, Sabir ALI, Nazia RIZIVI, Manish YADAV, Mohammad Kaleem AHMAD